Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation

Molecular and Cellular Biology

Volumn 20, Issue 13, 2000, Pages 4745-4753

  Vairo, Gino ^c   Soos, Timothy J ^a   Upton, Todd M ^b   Zalvide, Juan ^b   DeCaprio, James A ^b   Ewen, Mark E ^b   Koff, Andrew ^a   Adams, Jerry M ^d  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c ExGenix Operations PTY LTD   (Australia)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN P130; PROTEIN P27; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; ARTICLE; CELL CYCLE; CONTROLLED STUDY; GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; E2F4 TRANSCRIPTION FACTOR; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROTUBULE-ASSOCIATED PROTEINS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; RETINOBLASTOMA-LIKE PROTEIN P130; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0034082459     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.13.4745-4753.2000     Document Type: Article

References (51)

1. Adams, J. M., and S. Cory. 1998. The Bcl-2 protein family: arbiters of cell survival. Science 281:1322-1326.
2. Agrawal, D., P. Hauser, F. McPherson, F. Dong, A. Garcia, and W. J. Pledger. 1996. Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol. Cell. Biol. 16:4327-4336.
3. Biden, K. G., L. A. Simms, M. Cummings, R. Buttenshaw, E. Schoch, J. Searle, G. Gobe, J. R. Jass, S. J. Meltzer, B. A. Leggett, and J. Young. 1999. Expression of Bcl-2 protein is decreased in colorectal adenocarcinomas with microsatellite instability. Oncogene 18:1245-1249.
4. Brady, H. J. M., G. Gil-Gómez, J. Kirberg, and A. J. M. Berns. 1996. Baxα perturbs T cell development and affects cell cycle entry of T cells. EMBO J. 15:6991-7001.
5. Castaño, E., Y. Kleyner, and B. D. Dynlacht. 1998. Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor. Mol. Cell. Biol. 18:5380-5391.
6. Claudio, P. P., A. De Luca, C. M. Howard, A. Baldi, E. J. Firpo, A. Koff, M. G. Paggi, and A. Giordano. 1996. Functional analysis of pRb2/p130 interaction with cyclins. Cancer Res. 56:2003-2008.
7. Kip1-deficient cells. Curr. Biol. 9:163-173.
8. Cobrinik, D., M.-H. Lee, G. Hannon, G. Mulligan, R. T. Bronson, N. Dyson, E. Harlow, D. Beach, R. A. Weinberg, and T. Jacks. 1996. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev. 10:1633-1644.
9. DeGregori, J., G. Leone, A. Miron, L. Jakoi, and J. R. Nevins. 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94:7245-7250.
10. Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245-2262.
11. Evan, G., and T. Littlewood. 1998. A matter of life and cell death. Science 281:1317-1321.
12. Kip1 is haplo-insufficient for tumour suppression. Nature 396:177-180.
13. Furth, P. A., U. Bar-Peled, M. Li, A. Lewis, R. Laucirica, R. Jäger, H. Weiher, and R. G. Russell. 1999. Loss of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse model. Oncogene 18:6589-6596.
14. Furukawa, Y., S. Iwase, J. Kikuchi, M. Nakamura, H. Yamada, and M. Matsuda. 1999. Transcriptional repression of the E2F-1 gene by interferon-α is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes. Oncogene 18:2003-2014.
15. Ginsberg, D., G. Vairo, T. Chittenden, Z. X. Xiao, G. Xu, K. L. Wydner, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston. 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8:2665-2679.
16. Hengst, L., and S. I. Reed. 1996. Translational control of p27Kip1 accumulation during the cell cycle. Science 271:1861-1864.
17. Huang, D. C. S., L. A. O'Reilly, A. Strasser, and S. Cory. 1997. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J. 16:4628-4638.
18. Hurford, R. K., Jr., D. Cobrinik, M.-H. Lee, and N. Dyson. 1997. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11:1447-1463.
19. Iavarone, A., and J. Massague. 1999. E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest. Mol. Cell. Biol. 19:916-922.
20. Ikeda, M., L. Jakoi, and J. R. Nevins. 1996. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA 93:3215-3220.
21. Johnson, D. G. 1995. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. Oncogene 11:1685-1692.
22. Kip1. Cell 85:721-732.
23. Knowlton, K., M. Mancini, S. Creason, C. Morales, D. Hockenbery, and B. O. Anderson. 1998. Bcl-2 slows in vitro breast cancer growth despite its antiapoptotic effect. J. Surg. Res. 76:22-26.
24. Le Cam, L., J. Polanowska, E. Fabbrizio, M. Olivier, A. Philips, E. Ng Eaton, M. Classon, Y. Geng, and C. Sardet. 1999. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex. EMBO J. 18:1878-1890.
25. Lee, M.-H., B. O. Williams, G. Mulligan, S. Mukai, R. T. Bronson, N. Dyson, E. Harlow, and T. Jacks. 1996. Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev. 10:1621-1632.
26. Leone, G., J. DeGregori, Z. Yan, L. Jakoi, S. Ishida, R. S. Williams, and J. R. Nevins. 1998. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev. 12:2120-2130.
27. Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol. Cell 1:553-563.
28. Lind, E. F., J. Wayne, Q.-Z. Wang, T. Staeva, A. Stolzer, and H. T. Petrie. 1999. Bcl-2-induced changes in E2F regulatory complexes reveal the potential for integrated cell cycle and cell death functions. J. Immunol. 162:5374-5379.
29. Linette, G. P., Y. Li, K. Roth, and S. J. Korsmeyer. 1996. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc. Natl. Acad. Sci. USA 93:9545-9552.
30. Mazel, S., D. Burtrum, and H. T. Petrie. 1996. Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J. Exp. Med. 183:2219-2226.
31. Millard, S. S., J. S. Yan, H. Nguyen, M. Pagano, H. Kiyokawa, and A. Koff. 1997. Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest. J. Biol. Chem. 272:7093-7098.
32. Moberg, K., M. A. Starz, and J. A. Lees. 1996. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16:1436-1449.
33. Murphy, K. L., F. S. Kittrell, J. P. Gay, R. Jäger, D. Medina, and J. M. Rosen. 1999. Bcl-2 expression delays mammary tumor development in dimethylbenz(a)anthracene-treated transgenic mice. Oncogene 18:6597-6604.
34. Nevins, J. R. 1998. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9:585-593.
35. O'Reilly, L. A., D. C. S. Huang, and A. Strasser. 1996. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J. 15:6979-6990.
36. Puthier, D., C. Pellat-Deceunynck, S. Barille, N. Robillard, M. J. Rapp, N. Juge-Morineau, J. L. Harousseau, R. Bataille, and M. Amiot. 1999. Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancy. Leukemia 13:289-294.
37. Robanus-Maandag, E., M. Dekker, M. van der Valk, M. L. Carrozza, J. C. Jeanny, J. H. Dannenberg, A. Berns, and H. te Riele. 1998. p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev. 12:1599-1609.
38. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
39. Sherr, C. J., and J. M. Roberts. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501-1512.
40. Shiyanov, P., S. Hayes, N. Chen, D. G. Pestov, L. F. Lau, and P. Raychaudhuri. 1997. p27Kip1 induces an accumulation of the repressor complexes of E2F and inhibits expression of the E2F-regulated genes. Mol. Biol. Cell 8:1815-1827.
41. Smith, E. J., G. Leone, and J. R. Nevins. 1998. Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth. Cell Growth Differ. 9:297-303.
42. Strasser, A., A. W. Harris, and S. Cory. 1991. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889-899.
43. Strom, D. K., J. L. Cleveland, S. Chellappan, J. Nip, and S. W. Hiebert. 1998. E2f-1 and E2f-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation. Cell Growth Differ. 9:59-69.
44. Thornberry, N. A., T. A. Rano, E. P. Peterson, D. M. Rasper, T. Timkey, M. Garcia-Calvo, V. M. Houtzager, P. A. Nordstrom, S. Roy, J. P. Vaillancourt, K. T. Chapman, and D. W. Nicholson. 1997. A combinatorial approach defines specificities of members of the caspase family and granzyme B. J. Biol. Chem. 272:17907-17911.
45. Uhlmann, E. J., C. D'Sa-Eipper, T. Subramanian, A. J. Wagner, N. Hay, and G. Chinnadurai. 1996. Deletion of a nonconserved region of Bcl-2 confers a novel gain of function: suppression of apoptosis with concomitant cell proliferation. Cancer Res. 56:2506-2509.
46. Vairo, G., K. M. Innes, and J. M. Adams. 1996. Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival. Oncogene 13:1511-1519.
47. Vairo, G., D. M. Livingston, and D. Ginsberg. 1995. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9:869-881.
48. 0 exit of resting mouse embryo fibroblasts. Proc. Natl. Acad. Sci. USA 95:15583-15586.
49. Watanabe, G., C. Albanese, R. J. Lee, A. Reutens, G. Vairo, B. Henglein, and R. G. Pestell. 1998. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol. Cell. Biol. 18:3212-3222.
50. Zalvide, J., and J. A. DeCaprio. 1995. Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol. Cell. Biol. 15:5800-5810.
51. Zhu, L., L. Zhu, E. Xie, and L. S. Chang. 1995. Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins. Mol. Cell. Biol. 15:3552-3562.